Abu Dhabi, United Arab Emirates – Guests travelling with Etihad Airways from now until 31 May from Abu Dhabi to Chicago, New York, Washington and Toronto, will be the first to trial the IATA Travel Pass app to easily manage their travel health credentials. 

The IATA Travel Pass will enable Etihad guests to create a ‘digital passport’ to receive their Covid-19 test results and verify they are eligible to travel. Importantly, IATA Travel Pass will keep passengers in control of their data and facilitate the sharing of their test with airlines and authorities for travel. It will also make it convenient for passengers to manage their travel documents.   

Hosam Fouad, Chief Executive Officer, Life Diagnostics, said:  “During the current global situation, digital transformation has played a significant role in many industries. And with the dynamically changing health requirements for travel, Life Diagnostics believes that the digital health passport solution will provide additional clarity and ease for travelers. 

“We are proud to partner with Etihad Airways and IATA , so that together, we can provide  a globally unified approach to make travel easier once governments decide what regulations are required to cross borders in either direction.” 

To participate in the trial, guests simply download the IATA Travel Pass app from the Apple App Store and book an appointment with Life Diagnostics at Sultan Bin Zayed the First Street. 

Etihad Guests visiting Life Diagnostics need to inform front officers that they are participating in the IATA Travel Pass trial and should be ready to show their passport and mobile device with the IATA Travel Pass app downloaded. Once their test result is issued by Life Diagnostics, travellers will be able to view it on both the IATA Travel Pass app and also through the other standard reporting tools available at Life Diagnostics like SMS, email and Al HOSN App.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.